Panizzi Luca, Dittmer Keren E, Vignes Matthieu, Doucet Jennie S, Gedye Kristene, Waterland Mark R, Rogers Chris W, Sano Hiroki, McIlwraith C Wayne, Riley Christopher B
School of Veterinary Science, College of Science, Massey University, Palmerston North 4442, New Zealand.
School of Mathematical and Computational Sciences, College of Science, Massey University, Palmerston North 4442, New Zealand.
Animals (Basel). 2023 Mar 14;13(6):1053. doi: 10.3390/ani13061053.
Biomarkers for osteoarthritis (OA) in horses have been extensively investigated, but translation into clinical use has been limited due to cost, limited sensitivity, and practicality. Identifying novel biomarkers that overcome these limitations could facilitate early diagnosis and therapy. This study aimed to compare the concentrations of synovial fluid (SF) and plasma cell-free DNA (cfDNA) over time in control horses with those with induced carpal OA. Following an established model, unilateral carpal OA was induced in 9 of 17 healthy Thoroughbred fillies, while the remainder were sham-operated controls. Synovial fluid and plasma samples were obtained before induction of OA (Day 0) and weekly thereafter until Day 63, and cfDNA concentrations were determined using fluorometry. The SF cfDNA concentrations were significantly higher for OA joints than for sham-operated joints on Days 28 (median 1430 μg/L and 631 μg/L, respectively, = 0.017) and 63 (median 1537 μg/L and 606 μg/L, respectively, = 0.021). There were no significant differences in plasma cfDNA between the OA and the sham groups after induction of carpal OA. Plasma cfDNA measurement is not sufficiently sensitive for diagnostic purposes in this induced model of OA. Synovial fluid cfDNA measurement may be used as a biomarker to monitor early disease progression in horses with OA.
马骨关节炎(OA)的生物标志物已得到广泛研究,但由于成本、敏感性有限和实用性等原因,其在临床中的应用受到限制。识别能够克服这些局限性的新型生物标志物有助于早期诊断和治疗。本研究旨在比较诱导性腕关节OA马与对照马随时间变化的滑液(SF)和血浆游离DNA(cfDNA)浓度。按照既定模型,对17匹健康纯种小母马中的9匹诱导单侧腕关节OA,其余作为假手术对照。在诱导OA前(第0天)及此后每周直至第63天采集滑液和血浆样本,使用荧光法测定cfDNA浓度。在第28天(中位数分别为1430μg/L和631μg/L,P = 0.017)和第63天(中位数分别为1537μg/L和606μg/L,P = 0.021),OA关节的SF cfDNA浓度显著高于假手术关节。诱导腕关节OA后,OA组和假手术组血浆cfDNA无显著差异。在这种诱导性OA模型中,血浆cfDNA测量对诊断目的而言敏感性不足。滑液cfDNA测量可作为监测马OA早期疾病进展的生物标志物。